Week Ending April 19, 2021

World Liver Day: Here are some common myths about Hepatitis B & C
“In urban cities, one in every hundred people is diagnosed with Hepatitis B and Hepatitis C. This increases to four per hundred as we move to non-urban areas. Hepatitis B is an acute liver condition caused by the Hepatitis B virus, also known as HBV. This condition can affect your liver so severely that it could increase the risk of liver cancer or liver failure.”

What’s A Syndemic? Hepatitis C Among Injection Drug Users Is An Urgent Example
“What we have here is a syndemic, one that meets the following defining characteristics: two or more co-occurring population-level health threats; societal-level conditions or circumstances that facilitate the perpetuation of these health threats; and the synergistic interaction of these threats to produce an excess burden of disease at the population level.”

Treatment Of Chronic Hepatitis C In Young Children Reduces Adverse Outcomes: Study
“Recent research published in the Journal of Pediatrics has highlights that delaying treatment until age 18 years results in an increased lifetimes risk of late-stage liver complications and that early treatment in children is considered cost effective.”

Barriers to Hepatitis C Medication Adherence
“Research has identified 3 main prongs for low medication adherence among hepatitis C patients, including low awareness of the importance of adherence, according to a paper published in the Journal of Primary Care & Community Health.”

Hepatitis C rising dramatically in young people aged 20-39b
“While the world is focused on COVID-19, hepatitis C is rising dramatically in young people aged 20-39, Jeremy Eschliman, health director at the Two Rivers Public Health Department, said Wednesday.”

Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guidelines
“In the past 3 years, the FDA has approved 7 novel drugs, either given alone or in combination, to help treat patients with hepatocellular carcinoma (HCC).1